Editorial & Institutional Desk

IGC Pharma (IGC) Institutional & Peer Valuation Brief: Biotechnology & Specialty Pharma vs. PCSA, CRMD, and FBIO

By the PubCo Insight Editorial Desk, edited by Brad Listermann  ·  November 18, 2026
IGC
IGC IGC Pharma, Inc.
PubCo Insight Institutional & Sector Brief: Covering IGC Pharma, Inc. (NYSE: IGC) following its 2026-11-06 Form 10-Q. Prepared for PubCo Insight’s verified vault of 22,361 Active Microcap Traders, Prop Desks & Family Offices.

1. Balance Sheet, SEC Filing & Operating Context (2026-11-06 Form 10-Q)

IGC Pharma, Inc. (NYSE: $IGC, market capitalization ~$18.0M), led by Ram Mukunda, operates across clinical-stage pipeline execution, regulatory milestones, and specialty biopharma commercialization. Primary SEC EDGAR XBRL records reflect capital-markets disclosure via its 2026-04-20 Form 8-K, anchoring investor diligence around balance-sheet runway and commercial execution.

IGC price and volume
IGC price and volume, last 90 days. Source: Yahoo Finance.

2. Institutional & Family Office Peer Comparison ($PCSA, $CRMD, and $FBIO)

Across our institutional and active small-cap allocator screens benchmarking $IGC against $PCSA, $CRMD, and $FBIO, three factors stand out:

Free Public-Company AI & Investor Search Visibility Report

IGC Pharma, Inc. ($IGC) Investor Search & Diligence Audit

36 / 100
Visibility Score

Why This Costs $IGC Buyers & Volume: Before retail traders, family offices, or microcap funds buy a single share of $IGC, over 70% run a 30-second search across ChatGPT, Perplexity Finance, and TradingView. When prospective investors cannot find clean, current SEC figures or hit stale third-party data, they skip out, do not invest, and buy a peer instead. Here is what investors currently see when they search IGC Pharma, Inc.:

Investor Search SurfaceScoreWhere Prospective Buyers Are Dropping Off
ChatGPT & OpenAI Search33/100Missing root /llms.txt manifest and structured IR schema; surfaces stale baseline summaries instead of recent $IGC SEC filings.
Perplexity Finance & Citations40/100Pulls fragmented quote-scraper snippets instead of verified SEC EDGAR operating milestones and peer valuation context for $IGC.
TradingView, FactSet & Sector Screens35/100$IGC is omitted from AI discovery screens covering clinical-stage pipeline execution, regulatory milestones, and specialty biopharma commercialization due to unindexed entity and FAQPage metadata.
Turnkey Cleanup & Investor Distribution Package for IGC Pharma, Inc.: Pulse IR fixes how ChatGPT, Perplexity, TradingView, FactSet, Wikidata, and your IR page display $IGC directly from your SEC filings (requiring zero hours from your team), and then distributes your verified story to our 22,361 active microcap traders and 165 family offices and funds tracking your sector. To claim this report and review our turnkey package with CEO Brad Listermann, visit pulseir.co or call 424-250-0042.

Primary sources (SEC EDGAR)

IGC Primary SEC EDGAR Filings: https://www.sec.gov/edgar/browse/?CIK=0001326205
Compiled by the PubCo Insight Editorial & Institutional Desk from primary SEC EDGAR disclosures and market data. Published for informational and research purposes only, not investment advice or a buy/sell recommendation.
Investor relations · IGC
Is this how AI describes IGC Pharma, Inc.?
This page is the public, source-linked snapshot that investors, brokers, and AI assistants pull for IGC: EDGAR filings and recent news, no editor, no spin. When an AI engine or a financial terminal shows stale, misclassified, or missing data for your ticker, that is the first thing investors see. Pulse IR runs a free 24-hour audit of how ChatGPT, Perplexity, Google, and the major terminals currently represent IGC, and can correct it.
Get the free AI visibility audit
For company management and investor relations. Pulse IR is the investor-relations firm behind PubCo Insight.
See all IGC filings and data  ·  Uplist Radar  ·  Catalyst Radar  ·  Pulse IR Capital & Institutional Desk